Data demonstrate that CAR T-cells with induced release of IFNα and particularly IFNβ decline in number and anti-cancer cell activity under repetitive stimulatory conditions, which is far less the case for canonical CAR T-cells without IFN release. This evidence concerns the gene IFNB1 and cancer.